Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

U.S. top court to hear Bristol-Myers out-of-state injury appeal

Published 01/19/2017, 03:12 PM
Updated 01/19/2017, 03:20 PM
U.S. top court to hear Bristol-Myers out-of-state injury appeal

By Erica Teichert

(Reuters) - The U.S. Supreme Court on Thursday agreed to hear an appeal by pharmaceutical company Bristol-Myers Squibb Co (N:BMY) in a dispute involving its blood-thinning medication Plavix that could limit where corporations can be sued, the second such case it has taken up in the past week.

The justices will review a California Supreme Court decision allowing that state's courts to hear claims over Plavix even though the plaintiffs did not live in the state and the company is not based there.

Last Friday, the justices said they would decide a similar appeal by Texas-based BNSF Railway Co of a 2015 Montana Supreme Court ruling allowing out-of-state residents to sue there over injuries that occurred anywhere in BNSF's nationwide network.

Companies and plaintiffs are engaged in a fight over where lawsuits seeking compensation for injuries should be filed. Companies typically can be sued in a state where they are headquartered or incorporated, as well as where they have significant ties.

The California Supreme Court ruled in August 2016 that it could preside over the Plavix case because Bristol-Myers Squibb conducted a national marketing campaign and sold nearly $1 billion of the drug in the state.

Bristol-Myers and pharmaceutical industry groups argue that the ruling allows plaintiffs to bring lawsuits in states with more favorable laws, rather than where the company is based or where the alleged injury occurred.

Bristol-Myers is incorporated in Delaware and headquartered in New York.

The eight underlying lawsuits filed in 2012 against Bristol-Myers and California-based drug distributor McKesson Corp (NYSE:MCK) involve 84 California residents and 575 non-residents, alleging Plavix increased their risk of stroke, heart attack and internal bleeding.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The BNSF case involves a pair of lawsuits brought under the Federal Employers' Liability Act, which permits injured railroad employees to sue for compensation from their companies.

BNSF, a subsidiary of Berkshire Hathaway Inc (N:BRKa), argued that the Montana courts did not have jurisdiction over the cases. The Montana Supreme Court in May ruled that state courts there can hear cases against BNSF without violating due process rights of the U.S. Constitution because the company does business in the state.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.